Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Poseida Therapeutics Inc. logo

Poseida Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

3.25
 
USD
  
0.03
  
(0.93%)
Optionable: Yes  Market Cap: 336 M  90-day average vol: 959,792

Previous close: 3.22  Open: 3.23  Bid: 3.12  Ask: 3.68
52 week range    
1.54   
   5.98
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 26th February 2024
50
MarketXLS Rank
60
Value
53
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

PSTX Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22
Amortization of intangibles4 M
Basic EPS from continuing operations-2.01
Basic EPS total-2.01-0.89
Basic weighted shares outstanding36 M62 M72 M
Depreciation-3 M5 M
Depreciation unreconciled-5 M
DepreciationAndAmortization-3 M5 M-5 M
Diluted EPS total-3.61-2.01-0.89
Diluted normalized net income/share-3.61
Diluted weighted shares outstanding36 M62 M72 M
GeneralAndAdministrativeExpense23 M36 M38 M
Gross operating profit31 M130 M
Income before tax-130 M-125 M-63 M
Income taxes-9 M-139000.0544000.0
InterestExpenseNonOperating4 M3 M6 M
MiscOtherSpecialCharges280000.020 M3 M
Net income from total operations-130 M-125 M-64 M
NetIncomeCommonStockholders-130 M-125 M-64 M
NetIncomeContinuousOperations-130 M-125 M-64 M
NetNonOperatingInterestIncomeExpense-4 M-3 M-6 M
Normalized income-125 M
Operating income-127 M-141 M-60 M
Operating income before depreciation (EBITDA)-123 M-116 M-53 M
OperatingExpense127 M173 M-190 M
Other income net-280000.0-20 M-3 M
OtherGandA23 M36 M38 M
OtherImpairmentOfCapitalAssets-600000.0
OtherOperatingExpenses-3 M-4 M-2 M
RentAndLandingFees38 M
Research & development expense104 M137 M153 M
ResearchExpense104 M137 M153 M
Revenue per share4 M
SalariesAndWages-7 M-19 M
Selling Gen & administrative expense23 M36 M38 M
Total Income available for interest expense (EBIT)-126 M-122 M-57 M
Total common shares outstanding62 M63 M87 M
Total net income-130 M-125 M-64 M
Total ordinary shares96 M96 M96 M
Total revenues31 M130 M
TotalExpenses127 M173 M-190 M
TotalRevenue31 M130 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University